HealthQuill University of Cambridge
Cambridge researchers have developed a reactor that pulls carbon dioxide directly from the air and converts it into sustainable fuel, using sunlight as the power source.
Climate Health Research

Cambridge researchers develop solar reactor to make fuel from CO2

Cambridge researchers have developed a reactor that pulls carbon dioxide directly from the air and converts it into sustainable fuel, using sunlight as.

Read More
Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity that may lead to novel therapies.
Uncategorized

New obesity, diabetic cures may emerge as scientists unveil brain atlas 

Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity.

Read More
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Read More
Loneliness may contribute to a higher risk of heart disease, stroke and susceptibility to infections, according to a study conducted by the University of Cambridge and Fudan University involving 42,000 adults.
Drugs Health Research

Effects of loneliness, social isolation leave their mark on blood: Cambridge study

Loneliness may contribute to a higher risk of heart disease, stroke and susceptibility to infections, according to a study conducted by the University.

Read More
Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or conditions such as Parkinson’s, stroke or cerebral palsy.
Health Medical Pharma

‘Smart choker’ to help speech-impaired people talk with AI aid

Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or.

Read More
Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and a video game using the device, according to a video posted by billionaire Elon Musk’s X platform.
Drugs Health Medical

Mild concussions linked to long-term brain changes: Cambridge study

HQ Team August 22, 2024: Even a mild concussion could lead to long-term changes in the brain, according to a new study conducted.

Read More
A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely ineffective than a normal delivery, a study by the University of Cambridge found.
Drugs Health Pharma

Birth by C-section may double the chance of measles vaccine failure

HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.

Read More
Last year was the hottest summer in the Northern Hemisphere for the past two thousand years, researchers reveal after foraging through tree ring width data.
Climate Health Pharma

2023 comes up as hottest summer in 2,000 years: Scientists reveal

HQ Team May 14, 2024: Last year was the hottest summer in the Northern Hemisphere for the past two thousand years, researchers found.

Read More
The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory at the Milner Therapeutics Institute
Drugs Health Pharma

Cambridge Univ, AstraZeneca, MRC to set up genomics laboratory

HQ Team November 29, 2023: The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory.

Read More
DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of an antigen-based vaccine candidate to treat all coronaviruses.
Drugs Health Pharma

DIOSynVax to finish coronavirus vaccine trial in humans by month-end

HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of.

Read More